U.S. Army Turns to AI for Early Detection of Biological Threats

Summary

The U.S. Army’s 2026 Biodefense Strategy calls for combining environmental, clinical, logistics, chemical, biological, and intelligence data with artificial intelligence to identify emerging disease outbreaks before they spread widely or harm military forces. Officials said AI and machine learning will help integrate large volumes of biosurveillance data and accelerate predictive analysis, while human personnel remain involved in the process. Compared with the Army’s 2021 strategy, the new plan treats biodefense as a whole-of-Army operational priority rather than a localized medical or chemical specialty. Officials warned that the convergence of advanced biotechnology and AI is lowering barriers to engineering biological weapons, which adversaries could use to disrupt logistics, mobilization, deployment, and combat power. The Army also emphasized coordination with the Defense Department and other military services so that authorities and data systems are interoperable. Senior officials said the Army is working within a broader Pentagon approach and suggested that a department-wide biodeterrence posture is forthcoming. The strategy recognizes that AI advances in biomedicine are dual-use and that biological threats may change quickly. Tamasi said the strategy has no offensive component.